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ABSTRACT
Introduction. Thyroid nodules are common and fine-nee-
dle aspiration (FNA) biopsy is the standard of care for work-
up to exclude thyroid cancer. In this study, we examined 
the discrepancy between daily practice and recommended 
diagnostic approach for management of thyroid nodules, 
based on history taking, laboratory, and imaging studies.
Methods. This was a retrospective chart review of 199 pa-
tients who had ultrasound-guided fine needle aspira-
tion (UGFNA) performed at a Midwest academic medi-
cal center from January 2010 to December 2011. The 
quality measures were selected based on recommended clini-
cal practice guidelines, including family history, history of neck 
radiation, neck symptoms, TSH test, and thyroid ultrasound.
Results. The majority of patients were Caucasian females. Fam-
ily history of thyroid cancer and childhood neck radiation ex-
posure were documented in 79 subjects (40%) and 76 subjects 
(38%), respectively. Neck symptoms were documented in most 
subjects, including dysphonia (56.8%), dysphagia (69.9%), and 
dyspnea (41.2%). Most subjects had a TSH measured and an ul-
trasound performed prior to biopsy (75% and 86%, respectively).
Conclusions.   It appears there is a gap between current patient 
care and clinical practice guidelines for management of thyroid 
nodules. Clinical history and ultrasound features for risk strati-
fication of UGFNA were lacking, which could reflect physicians’ 
unfamiliarity with the guidelines. As thyroid nodules are com-
mon, enhancing knowledge of the current guidelines could im-
prove appropriate work-up. Further studies are needed to identify 
factors associated with the poor compliance with clinical guide-
lines in management of thyroid nodules. KS J Med 2017;10(1):1-2.
INTRODUCTION
  Thyroid nodules are very common with an estimated preva-
lence of 4 - 7% by palpation1-3 and up to 30 - 60% based on autop-
sy studies.3 Fine-needle aspiration (FNA) biopsy is the standard 
of care for work-up and exclusion of thyroid cancer. Around 5 
- 15% of thyroid nodules are malignant, but the malignancy risk 
increases based on age, sex, history of head and neck radiation, 
and family history.1,4 The incidence of thyroid cancer increased 
by 2.4 fold from 1973 to 20025, which is likely due to increasing 
use of ultrasound (US). Various practice guidelines for manage-
ment of thyroid nodules have been published, including the most 
recent 2015 American Thyroid Association (ATA)6 guideline. 
Clinical risk factors of malignancy include childhood radiation 
exposure, rapid growth of a nodule, hoarseness, vocal cord pa-
ralysis, dysphagia, or a family history of thyroid cancer or mul-
tiple endocrine neoplasia syndromes. Suspicious US features in-
clude hypoechogenicity, microcalcifications, taller than wide on 
transverse view, or infiltration of the surrounding tissue. ATA 
recommends FNA based on sizes and sonographic patterns, 
starting at 1 cm with intermediate to high suspicion patterns.
 A serum thyroid-stimulating hormone (TSH) level 
should be obtained in all patients. If TSH is suppressed, 
a radionuclide thyroid scan (I-SCAN) should be ob-
tained. FNA generally is not indicated for hyperfunc-
tioning nodules due to low likelihood of malignancy. 
 In this study, we examined the discrepancy between daily 
practice and recommended diagnostic approach to thyroid nod-
ules, based on history taking, laboratory, and imaging studies.
METHODS
 Patients who underwent ultrasound-guided FNA (UGFNA) 
at our institution during January 1, 2010 to December 31, 2011 
were retrospectively reviewed. The date range was chosen to 
begin following the revised ATA guideline published in 2009. 
We randomly selected 200 subjects and one patient was ex-
cluded due to duplicate records. Patients with previous his-
tory of thyroid cancer or thyroid surgery were excluded. The 
study protocol was approved by the local institutional review 
board. Data abstraction from the electronic medical record were 
entered in REDcap7, including demographic information, rel-
evant clinical history including family history of thyroid can-
cer, history of childhood neck radiation, neck symptoms, TSH 
values, suspicious ultrasound characteristics, and I-SCAN re-
sults. The quality measures were determined based on five 
categories: (1) documentation of family history of thyroid 
cancer, (2) documentation of history of childhood neck radia-
tion, (3) documentation of neck symptoms including dyspho-
nia, dysphagia, and dyspnea, (4) presence of TSH values prior 
to UGFNA, and (5) presence of thyroid US prior to UGFNA. 
 The ultrasound results were categorized according to nod-
ules sizes, number of nodules, echogenicity, presence of mi-
crocalcification, presence of irregular margins, presence of 
suspicious cervical lymph nodes, and evidence of growth from 
previous US. All analyses were conducted using SAS statisti-
cal software, version 9.4 (SAS Institute, Inc., Cary, NC, USA).
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RESULTS
 There were 833 UGFNA cases performed at our institution 
during January 1, 2010 to December 31, 2011. The 199 random-
ly-selected patients represented 273 FNA cases. The study 
group consisted of 37 (18.6%) males and 162 (81.4%) females, 
with a mean age of 55 ± 14 years. Of these, 72.9% were Cau-
casian. Forty-four percent had hypertension, 18.6% had type 
2 diabetes mellitus, and 13.6% had coronary artery disease. 
 Nearly 40% were questioned about family history of thy-
roid cancer and childhood neck radiation history. Neck 
symptoms were assessed for dysphonia, dysphagia, and dys-
pnea in 58%, 70%, and 39% of subjects, respectively (Table 1). 
TSH value was documented in 75%; 86% of patients had an 
ultrasound performed prior to biopsy. The ultrasound de-
scriptions of 273 thyroid nodules are summarized in Table 
2. None specified nodules which were taller than wide on 
transverse view. I-SCAN was performed in 10% of subjects.
Table 1. Findings of concordance quality measures. 
Concordance Quality Measures Documented (%)
Family History of Thyroid Cancer 79 (39.7)
Childhood Radiation Exposure 76 (38.2)
Symptoms of Dysphonia 113 (56.8)
Symptoms of Dysphagia 139 (69.9)
Symptoms of Dyspnea 82 (41.2)
Presence of TSH values prior to UGFNA 149 (74.9)
Presence of thyroid US prior to UGFNA 171 (85.9)
 
Table 2. Findings of ultrasound description of thyroid 
nodules. 
Ultrasound Description Number of Nodules (%)
Consistency (presence of solid, 
cystic, or mixed nodules) 135 (49.6)
Echogenicity 98 (36.0)
Presence or Absence of 
Microcalcification 52 (19.1)
Margin of Nodules 112 (41.1)
Cervical Lymphadenopathy 146 (53.7)
Evidence of Growth 80 (29.4)
 Most FNA specimens were categorized as benign (81%). In-
determinate cytology, cytology suspicious for malignancy, and 
malignant cytology were found in 8%, 6%, and 1% of subjects, 
respectively. Surgery was performed on 78 subjects (29%), 
and 14 subjects (7%) were confirmed to have thyroid cancer.
DISCUSSION
The results showed that history-taking to identify clinical 
risk factors for thyroid cancer were lacking in more than 50% 
of patients. The majority of patients appropriately had TSH 
value and thyroid ultrasound performed prior to UGFNA as 
recommended by the guidelines. There was also significant dis-
crepancy among sonographic description of thyroid nodules.
Tangpricha et al.8 reported in 1999 that the American As-
sociation of Clinical Endocrinologists guidelines had not 
been implemented fully among patients that presented with 
thyroid nodules. They also found that endocrine referral in-
creased the rate of FNA performance, and the use of I-SCAN 
seemed to be over utilized (90%).8 The majority of our sub-
jects were evaluated by primary care physicians and otolar-
yngologists, not endocrinologists. I-SCAN was performed 
less frequently in our study, which reflected a minority of 
patients with low TSH. Radionuclide studies have become 
less utilized at present time, most likely due to the evolution 
of thyroid ultrasound and increased availability of FNA.9 
The retrospective chart review design limits the interpretation 
of the findings. Our study is limited to FNA cases from our institu-
tion and could underestimate the number of biopsies performed 
at an outside institution. In this current study, we examined the 
discrepancy between daily practice and recommended guide-
lines. In future studies, we plan to examine whether adherence 
to guidelines could impact early discovery of thyroid cancer. 
A gap was revealed between current patient care and the rec-
ommended approach for management of thyroid nodules. Clini-
cal history and US features for risk stratification of UGFNA were 
lacking, which could reflect physicians’ unfamiliarity with clini-
cal practice guidelines. As thyroid nodules are common, improve-
ment of knowledge of the current guidelines would be beneficial.
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